154 related articles for article (PubMed ID: 8352519)
1. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
Bregant F; Pacor S; Ghosh S; Chattopadhyay SK; Sava G
Anticancer Res; 1993; 13(4):1011-7. PubMed ID: 8352519
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma.
Sava G; Pacor S; Ceschia V; Zassinovich G; Mestroni G
Anticancer Res; 1989; 9(3):787-90. PubMed ID: 2764524
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity.
Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G
Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985
[TBL] [Abstract][Full Text] [Related]
4. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
[TBL] [Abstract][Full Text] [Related]
7. In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.
Bergamo A; Masi A; Peacock AF; Habtemariam A; Sadler PJ; Sava G
J Inorg Biochem; 2010 Jan; 104(1):79-86. PubMed ID: 19906432
[TBL] [Abstract][Full Text] [Related]
8. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A.
Pacor S; Vadori M; Vita F; Bacac M; Soranzo MR; Zabucchi G; Sava G
Anticancer Res; 2001; 21(4A):2523-30. PubMed ID: 11724317
[TBL] [Abstract][Full Text] [Related]
10. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
Sava G; Ceschia V; Pacor S; Zorzet S; Perissin L
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):683-9. PubMed ID: 2622298
[TBL] [Abstract][Full Text] [Related]
12. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure and spectral and redox properties of new mixed ligand monomeric and dimeric Ru(II) complexes: predominant formation of the "cis-alpha" diastereoisomer and unusual 3MC emission by dimeric complexes.
Murali M; Palaniandavar M
Dalton Trans; 2006 Feb; (5):730-43. PubMed ID: 16429178
[TBL] [Abstract][Full Text] [Related]
14. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
15. Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.
Djinović V; Momcilović M; Grgurić-Sipka S; Trajković V; Mostarica Stojković M; Miljković D; Sabo T
J Inorg Biochem; 2004 Dec; 98(12):2168-73. PubMed ID: 15541507
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
17. Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.
Sava G; Pacor S; Bergamo A; Cocchietto M; Mestroni G; Alessio E
Chem Biol Interact; 1995 Mar; 95(1-2):109-26. PubMed ID: 7697744
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
Pacor S; Zorzet S; Cocchietto M; Bacac M; Vadori M; Turrin C; Gava B; Castellarin A; Sava G
J Pharmacol Exp Ther; 2004 Aug; 310(2):737-44. PubMed ID: 15075381
[TBL] [Abstract][Full Text] [Related]
19. Mixed-valent metals bridged by a radical ligand: fact or fiction based on structure-oxidation state correlations.
Sarkar B; Patra S; Fiedler J; Sunoj RB; Janardanan D; Lahiri GK; Kaim W
J Am Chem Soc; 2008 Mar; 130(11):3532-42. PubMed ID: 18290644
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
